Citi raised the firm’s price target on Universal Health to $170 from $163 and keeps a Buy rating on the shares. The analyst update target prices across the healthcare services sector as the firm considers market multiples, although it remains cognizant “of the inherent risks within this balanced backdrop.” The analyst believes investors will look to be more selective and find value within names that can manage and show resiliency, and/or those that have high conviction stories.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on UHS:
- Early notable gainers among liquid option names on November 17th
- Universal Health price target lowered to $144 from $152 at JPMorgan
- UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDEND
- Universal Health price target raised to $144 from $139 at Wells Fargo
- Universal Health price target lowered to $140 from $152 at RBC Capital